UROLOGIC SURVEY

J Urol Surg 2017; 4: 150-150
Received Date:
Accepted Date:
*

Re: Preclinical Evaluation of a TEX101 Protein ELISA Test for the Differential Diagnosis of Male İnfertility

EDITORIAL COMMENT

Seminal plasma (SP) is enriched with testis-derived proteins, mRNA and metabolites. Due to blood-testis and blood-epididymis barriers, testis-specific biomarkers are not found in blood serum. Therefore, evaluation of semen and SP could be an option for non-invasive diagnosis of male infertility. In this study, the authors evaluated the performance of TEX101 ELISA in large cohort of fertile, subfertile and infertile men besides the validation of this test as a prognostic biomarker of sperm retrieval in patients with non-obstructive azoospermia (NOA). Impressively, TEX101 differentiated between pre- and post-vasectomy samples with 100% sensitivity and 100% specificity. As a marker of differentiation between NOA and obstructive azoospermia, combination of TEX101 with ECM1 increased sensitivity to detect NOA from 69% to 81% at 100% specificity. In addition, a cut-off value of TEX101 ≥0.6 ng/mL provided 73% sensitivity at 64% specificity for predicting sperm or spermatid retrieval in men with NOA. The prediction of sperm retrieval by TEX101 was comparable to blood serum protein (the area under the curve value=0.64; 71% sensitivity at 68% specificity) (1). Testicular sperm extraction is still the only option for men with NOA. Most of the patients and supposes accept sperm extraction procedure even if they had a very little chance of sperm recovery. Better biomarkers to predict sperm recovery from testicular sperm extraction operation in NOA patients are still required.


References

1.    Ma Y, Chen B, Wang H, Hu K, Huang Y. Prediction of sperm retrieval in men with non-obstructive azoospermia using artificial neural networks: leptin is a good assistant diagnostic marker. Hum Reprod 2011;26:294-298.

Home Archive Search Menu